14-day Premium Trial Subscription Try For FreeTry Free
$83.80
+0.470 (+0.564%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $80.50 $93.35 Thursday, 2nd May 2024 BMRN stock ended at $83.80. This is 0.564% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.43% from a day low at $81.43 to a day high of $85.04.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Nov 02, 2022 $86.12 $86.22 $84.07 $84.17 1 917 509
Nov 01, 2022 $87.24 $89.06 $86.13 $86.60 1 611 132
Oct 31, 2022 $89.06 $89.06 $85.14 $86.63 1 548 034
Oct 28, 2022 $85.67 $86.95 $84.30 $86.77 2 084 309
Oct 27, 2022 $89.63 $89.63 $83.10 $85.73 4 289 036
Oct 26, 2022 $91.58 $92.76 $91.43 $92.10 1 614 514
Oct 25, 2022 $89.63 $91.66 $89.45 $91.47 1 633 462
Oct 24, 2022 $89.99 $90.80 $89.45 $89.87 974 438
Oct 21, 2022 $89.30 $90.81 $88.94 $90.01 1 302 544
Oct 20, 2022 $88.04 $89.70 $87.95 $88.70 905 628
Oct 19, 2022 $88.45 $89.43 $87.80 $88.35 1 157 921
Oct 18, 2022 $89.84 $90.54 $88.56 $89.49 1 487 047
Oct 17, 2022 $87.31 $89.51 $87.31 $88.78 961 258
Oct 14, 2022 $89.89 $90.31 $87.13 $87.25 1 177 103
Oct 13, 2022 $87.44 $90.37 $87.17 $89.40 1 989 866
Oct 12, 2022 $88.67 $89.69 $88.02 $88.95 828 669
Oct 11, 2022 $87.42 $89.04 $87.12 $88.07 1 222 239
Oct 10, 2022 $87.84 $88.81 $87.39 $87.45 967 949
Oct 07, 2022 $91.16 $91.16 $87.63 $88.15 1 075 952
Oct 06, 2022 $89.25 $92.06 $88.75 $91.48 1 539 197
Oct 05, 2022 $87.89 $89.82 $87.40 $89.53 1 276 492
Oct 04, 2022 $87.18 $88.08 $85.76 $87.91 1 439 554
Oct 03, 2022 $85.64 $87.43 $84.57 $86.70 930 643
Sep 30, 2022 $84.99 $86.75 $84.51 $84.77 1 437 083
Sep 29, 2022 $85.65 $85.79 $84.27 $85.06 788 016
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT